improve News newsbot.ch

Wirtschaft »

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

2019-05-16 08:40:14


Wirtschaft »

Roche’s personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents

2019-05-16 08:40:14


Wirtschaft »

New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world’s leading cause of infectious disease deaths

2019-05-14 05:20:02


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

2019-05-10 05:20:01


Wirtschaft »

Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting

Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting

2019-05-07 06:20:00


Wirtschaft »

FDA approves Roche’s Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment

FDA approves Roche’s Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment

2019-05-06 06:40:01


Wirtschaft »

New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio

2019-04-29 17:20:00


Wirtschaft »

Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy

2019-04-23 05:20:30


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-04-03 15:40:15


Wirtschaft »

Roche’s ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial

2019-04-01 12:20:05


Wirtschaft »

FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

2019-03-19 07:20:00


Wirtschaft »

European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

2019-03-15 10:20:24


Wirtschaft »

European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors

2019-03-14 06:40:00


Wirtschaft »

Roche’s VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane

2019-03-11 08:40:04


Wirtschaft »

FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-03-11 08:40:04


Wirtschaft »

European Commission approves Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

2019-03-08 10:20:06


Wirtschaft »

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash

2019-03-07 19:20:03


Wirtschaft »

Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions

2019-03-07 14:20:29


Wirtschaft »

FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers

FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers

2019-02-28 22:40:37



Suchresultate als RSS-Feed